x Health Men's Health Children's Health Nutrition and Wellness Reproductive Health Health & Science Digital News Videos Opinions Cartoons Education E-Paper Lifestyle & Entertainment Nairobian Entertainment Eve Woman Travelog TV Stations KTN Home KTN News BTV KTN Farmers TV Radio Stations Radio Maisha Spice FM Vybez Radio Enterprise BULK SMS E-Learning Digger Classified The Standard Group Corporate Contact Us Rate Card Vacancies DCX O.M Portal Corporate Email RMS
Login ×
BTV
VAS
DCX
RMS

Pfizer to start pilot delivery program for its Covid-19 vaccine in four U.S. states

Health & Science - By Reuters | November 17th 2020 at 07:54:49 GMT +0300

FILE PHOTO: Vials with a sticker reading, "Covid-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Pfizer logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/Illustration/File Photo

Pfizer Inc PFE.N has launched a pilot delivery program for its experimental Covid-19 vaccine in four U.S. states, as the U.S. drugmaker seeks to address distribution challenges facing its ultra-cold storage requirements.

Pfizer’s vaccine, which was shown to be more than 90 per cent effective in preventing Covid-19 based on initial data, must be shipped and stored at -70 degrees Celsius (minus 94°F), significantly below the standard for vaccines of 2-8 degrees Celsius (36-46°F).

“We are hopeful that results from this vaccine delivery pilot will serve as the model for other U.S. states and international governments, as they prepare to implement effective Covid-19 vaccine programs,” Pfizer said in a statement on Monday.

It picked Rhode Island, Texas, New Mexico, and Tennessee for the program after taking into account their differences in overall size, diversity of populations, immunization infrastructure, and need to reach individuals in varied urban and rural settings.

The four states will not receive vaccine doses earlier than other states by virtue of the pilot, nor will they receive any differential consideration, Pfizer said.

The company expects to have enough safety data on the vaccine from the ongoing large scale late-stage trials by the third week of November before proceeding to apply for emergency use authorization (EUA).

Pfizer and its partner BioNTech SE 22UAy.F have a $1.95 billion deal to supply 100 million doses of the vaccine to the U.S. government, which has an option to acquire up to an additional 500 million doses.

Earlier on Monday, rival Moderna Inc MRNA.O said its experimental vaccine was 94.5% effective in preventing Covid-19 based on interim data from a late-stage trial, boosting hopes that vaccines against the disease may be ready for use soon.

Both the Pfizer and Moderna vaccines use a new technology called synthetic messenger RNA to activate the immune system against the virus.

Top Stories

COVID-19 shots to cost between Sh300 and Sh1100 under African Union vaccine plan
Health & Science - By Reuters


80 test positive for coronavirus in Kenya today
Health & Science - By Jael Mboga


Woman's cry for justice after losing uterus in wrong surgery
Health & Science - By Mactilda Mbenywe


Covid-19: Kenya records 136 new cases as 176 recover
Health & Science - By Judah Ben-Hur


No coronavirus deaths in Kenya today - Health ministry
Health & Science - By Jael Mboga


We'll go on with strike, healthcare workers say
Health & Science - By Anyango Otieno and Kirsten Kanja


Medication mistakes you should avoid
Health & Science - By Standard Digital


Alcoholism blamed for high TB prevalence in Kiambu
Health & Science - By Kamau Maichuhie


Sampuli ya magonjwa yanayoathiri viungo mwilini
Health & Science - By Is`haq Gunga Chea


Latest Stories

We'll go on with strike, healthcare workers say
Health & Science - By Anyango Otieno and Kirsten Kanja


COVID-19 shots to cost between Sh300 and Sh1100 under African Union vaccine plan
Health & Science - By Reuters


Covid-19: Kenya records 136 new cases as 176 recover
Health & Science - By Judah Ben-Hur


Muslim Council calls on governors to heal health crisis
Health & Science - By Judah Ben-Hur


I eagerly await my baby's first steps
Health & Science - By Mactilda Mbenywe


President urges striking medics to return to work
Health & Science - By Wainana Ndung’u and Kennedy Gachuhi


No coronavirus deaths in Kenya today - Health ministry
Health & Science - By Jael Mboga


A virus that reverses deafness
Health & Science - By Killiad Sinide


I survived the deadliest cancer
Health & Science - By Yvonne Kawira


 When should you be worried about delayed milestones?
Health & Science - By Nancy Nzalambi


//

Stay Ahead!

Access premium content only available
to our subscribers.

Or Login With Your Standard Account
Support independent journalism
×
Create An Account
Support independent journalism
I have an account Log in
Reset Password
Support independent journalism
Log in